Skip to main content
letter
. 2020 Feb 26;183(1):169–171. doi: 10.1111/bjd.18899

Table 1.

Differences between various diseases regarding the aspects of shame, visibility of skin disease and duration of disease

Variable Disease duration ≥ 5 years, n (%)b Age (years) SSS‐24 (score) SHAME bodily SHAME cognitive SHAME existential SHAME summary score
Total 61 (50) 43·5 ± 17·8 57·8 ± 18·0 2·60 ± 1·07 4·00 ± 1·18 1·84 ± 0·92 2·81 ± 0·81
P 30 (77) 47·9 ± 14·6 65·3 ± 17·6 2·42 ± 0·99 3·98 ± 1·19 1·69 ± 0·74 2·69 ± 0·76
T 7 (39) 51·7 ± 20·1 48·5 ± 15·1 2·47 ± 1·06 3·79 ± 1·37 1·90 ± 0·97 2·72 ± 0·83
ID 8 (36) 40·7 ± 18·5 65·1 ± 15·6 2·60 ± 1·09 4·09 ± 1·20 1·78 ± 0·93 2·83 ± 0·82
I 5 (29) 33·7 ± 14·7 53·6 ± 18·2 2·88 ± 1·13 4·24 ± 0·92 2·05 ± 1·09 3·05 ± 0·76
A 5 (45) 43·4 ± 15·1 48·9 ± 15·6 2·62 ± 0·98 3·96 ± 1·14 1·83 ± 0·81 2·81 ± 0·79
E 6 (38) 34·7 ± 15·6 62·6 ± 17·5 2·86 ± 1·20 4·04 ± 1·11 1·92 ± 1·14 2·94 ± 0·95
  χ2 = 17·8** , c F = 5·88*** F = 8·29*** F = 0·43 F = 0·15 F = 0·71 F = 0·39
P = 0·003 P = 0·001 P < 0·001 P > 0·05 P > 0·05 P > 0·05 P > 0·05
η2 = 0·13d η2 = 0·18e
Visible 61·6 ± 17·3 2·68 ± 1·10 4·06 ± 1·15 1·90 ± 1·01 2·88 ± 0·82
Invisible 53·1 ± 17·5 2·47 ± 0·99 3·92 ± 1·25 1·77± 0·75 2·72 ± 0·78
F = 9·88** F = 1·56 F = 0·59 F = 0·84 F = 1·64
P = 0·002 P > 0·05 P > 0·05 P > 0·05 P > 0·05
η2 = 0·05
< 5 yearsa 58·9 ± 17·8 2·64 ± 1·00 4·06 ± 1·11 1·86 ± 0·81 2·85 ± 0·72
≥ 5 yearsa 65·4 ± 16·4 2·50 ± 1·00 4·15 ± 1·18 1·68 ± 0·82 2·78 ± 0·77
  F = 4·42* F = 0·55 F = 0·17 F = 1·53 F = 0·56
P = 0·038 P > 0·05 P > 0·05 P > 0·05 P > 0·05
η2 = 0·04
Patients 57·8 ± 18·0 2·60 ± 1·07 4·00 ± 1·18 1·84 ± 0·92 2·81 ± 0·82
Controls 44·6 ± 13·7 2·79 ± 1·03 4·24 ± 0·95 1·59 ± 0·68 2·87 ± 0·71
F = 108·02*** F = 4·96 F = 7·94** F = 15·94*** F = 0·97
P < 0·001 P > 0·05 P = 0·003 P < 0·001 P > 0·05
η2 = 0·14 η2 = 0·01 η2 = 0·02

The data are presented as the mean ± SD unless stated otherwise. SSS‐24, Skin Shame Scale; SHAME, Shame Assessment scale for Multifarious Expression of shame; A, allergic diseases (n = 27); E, eczema (n = 22), ID; inflammatory diseases (n = 35); I, infection (n = 27); P, psoriasis (n = 49); T, tumours (n = 41). aDisease duration. bMissing data for 78 individuals. c,d,ePost hoc (significant differences): cP > T = ID = E = I = A; dP = T > I = E; eP = E = ID > T = A. *P < 0·05, **P < 0·01, ***P < 0·001. The exact P‐value is stated for all significant comparisons (except for P < 0.001).